Opiant Pharmaceuticals logo
Opiant Pharmaceuticals OPNT

Quartalsbericht 2022-Q3
hinzugefügt 14.11.2022

report update icon

Opiant Pharmaceuticals DSO 2011-2026 | OPNT

DSO Jährlich Opiant Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
84.9 110 65 117 74.2 11.5 - - - 86.2 -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
117 11.5 78.4

DSO Vierteljährlich Opiant Pharmaceuticals

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- 624 79.5 181 - 70.2 62.1 104 - 89.3 129 172 - 31.9 97.2 98.3 - 93.8 130 434 78.9 48.5 K 283 24.3 K 4.65 41.2 4.09 12.7 - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
48.5 K 4.09 3.29 K

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
Celldex Therapeutics Celldex Therapeutics
CLDX
321 $ 34.55 2.04 % $ 2.29 B usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
16.2 K $ 4.47 12.59 % $ 10.8 B australiaAustralia
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
58.1 $ 309.66 -3.27 % $ 40.6 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
70.9 $ 22.88 4.91 % $ 1.07 B usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
16.8 - -13.39 % $ 1.45 M usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 3.04 -1.3 % $ 5 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
103 $ 1.15 7.48 % $ 14 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
62.9 $ 1.41 4.07 % $ 363 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
103 $ 4.32 1.41 % $ 462 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
106 $ 24.53 1.41 % $ 3.12 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
115 - -4.8 % $ 255 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
58.2 $ 1.6 -0.62 % $ 426 M britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
bluebird bio bluebird bio
BLUE
2.47 - - $ 546 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
Cidara Therapeutics Cidara Therapeutics
CDTX
2.26 K - - $ 1.41 B usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
182 - - $ 3.45 B usaUSA